KUALA LUMPUR: Alpha IVF Group Bhd remains confident of sustaining its growth trajectory for the financial year ending May 31, 2026 (FY26), supported by rising patient demand and the opening of new centres.
In a statement, the fertility care specialist said the group will continue to strengthen its presence in existing markets while pursuing new opportunities to deliver sustainable, long-term value to shareholders.
In the first quarter ended Aug 31 (1Q26), Alpha IVF posted a higher net profit of RM15.3mil, or earnings per share of 0.31 sen, compared with RM14.4mil, or 0.29 sen, in the corresponding quarter last year.
Quarterly revenue rose 21.2% to RM52.1mil versus RM43mil previously.
Malaysia remained the group’s main growth driver, contributing RM47.9mil, or 92% of total revenue in 1Q26, compared with RM35.4mil, or 82.3%, in 1Q25.
Singapore operations contributed RM3.9mil, or 7.5% of total revenue, compared to RM7.6mil, or 17.7%, previously.
The group’s fledgling operations in Indonesia contributed RM241,000, or 0.5%, as the group continues to build its presence in the market.
“It’s been a solid start to the year for Alpha IVF Group. We’re seeing strong demand from both local and foreign patients, as awareness and access to fertility treatment continue to grow across the region,” said group managing director Datuk Dr Colin Lee Soon Soo.
“Our expansion in Malaysia, Indonesia, and soon the Philippines puts us in a strong position to serve more patients and strengthen our regional network.
“As new centres and satellite clinics become operational in FY26, we expect sustained growth in patient volumes, operational efficiency, and long-term shareholder value,” he said.
Alpha IVF Group will establish one new full-fledged IVF centres in Sabah, Malaysia, and another regional IVF centre in Manila, the Philippines.
In Indonesia, the group is expanding its presence with two new satellite clinics — the first commenced operations in 1Q26, while the second is scheduled to open in 2Q26.
Upon completion of these expansion initiatives, the group’s network is expected to expand from seven facilities at the start of FY26 to eleven by year-end, comprising six full-fledged IVF centres, two sales offices, and three satellite clinics.
